GATA4 negatively regulates bone sialoprotein expression in osteoblasts
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
GATA4 has been reported to act as a negative regulator in osteoblast differentiation by inhibiting the Dlx5 transactivation of Runx2 via the attenuation of the binding ability of Dlx5 to the Runx2 promoter region. Here, we determine the role of GATA4 in the regulation of bone sialoprotein (Bsp) in osteoblasts. We observed that the overexpression of Runx2 or Sox9 induced the Bsp expression in osteoblastic cells. Silencing GATA4 further enhanced the Runx2- and Sox9- mediated Bsp promoter activity, whereas GATA4 overexpression down-regulated Bsp promoter activity mediated by Runx2 and Sox9. GATA4 also interacted with Runx2 and Sox9, by attenuating the binding ability of Runx2 and Sox9 to the Bsp promoter region. Our data suggest that GATA4 acts as a negative regulator of Bsp expression in osteoblasts.
Abstract
GATA4 has been reported to act as a negative regulator in osteoblast differentiation by inhibiting the Dlx5 transactivation of Runx2 via the attenuation of the binding ability of Dlx5 to the Runx2 promoter region. Here, we determine the role of GATA4 in the regulation of bone sialoprotein (Bsp) in osteoblasts. We observed that the overexpression of Runx2 or Sox9 induced the Bsp expression in osteoblastic cells. Silencing GATA4 further enhanced the Runx2- and Sox9- mediated Bsp promoter activity, whereas GATA4 overexpression down-regulated Bsp promoter activity mediated by Runx2 and Sox9. GATA4 also interacted with Runx2 and Sox9, by attenuating the binding ability of Runx2 and Sox9 to the Bsp promoter region. Our data suggest that GATA4 acts as a negative regulator of Bsp expression in osteoblasts.
참고문헌 (24)
- 김정하, "Signaling Pathways in Osteoclast Differentiation", 전남의대학술지, 52(1), pp.12~17 (2016), 의과학연구소
- Walsh MC, "Osteoimmunology : interplay between the immune system, bone metabolism", Annu Rev Immunol, 24, pp.33~63 (2006)
- Komori T, "Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts", Cell, 89, pp.755~764 (1997)
- Otto F, "Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation, bone development", Cell, 89, pp.765~771 (1997)
- Lee B, "Missense mutations abolishing DNA binding of the osteoblastspecific transcription factor OSF2", CBFA1 in cleidocranial dysplasia, 1997, pp.16, 307~310
- Hong JH, "TAZ, a transcriptional modulator of mesenchymal stem cell differentiation", Science, 309, pp.1074~1078 (2005)
- Lee MH, "Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter", J Biol Chem, 280, pp.35579~35587 (2005)
- Zhou G, "Dominance of SOX9 function over RUNX2 during skeletogenesis", Proc Natl Acad Sci U S A, 103, pp.19004~19009 (2006)
- Marie PJ, "Transcription factors controlling osteoblastogenesis", Arch Biochem Biophys, 473, pp.98~105 (2008)
- Gubbay J, "Normal structure, expression of Zfy genes in XY female mice mutant in Tdy", Development, 109, pp.647~653 (1990)
- Jo A, "The versatile functions of Sox9 in development, stem cells, and human diseases", Genes Dis, 1, pp.149~161 (2014)
- Ikeda T, "The combination of SOX5, SOX6, and SOX9(the SOX trio)provides signals sufficient for induction of permanent cartilage", Arthritis Rheum, 50, pp.3561~3573 (2004)
- Molkentin JD, "The zinc finger-containing transcription factors GATA-4, -5, and-6. Ubiquitously expressed regulators of tissue-specific gene expression", J Biol Chem, 275, pp.38949~38952 (2000)
- Viger RS, "Role of the GATA family of transcription factors in endocrine development, function, and disease", Mol Endocrinol, 22, pp.781~798 (2008)
- Pikkarainen S, "GATA transcription factors in the developing, adult heart", Cardiovasc Res, 63, pp.196~207 (2004)
- Foster BL, "Deficiency in acellular cementum, periodontal attachment in bsp null mice", J Dent Res, 92, pp.166~172 (2013)
- Ganss B, "Bone silaoprotein", Crit Rev Oral Biol Med, 10, pp.79~98 (1999)
- Fisher LW, "Six genes expressed in bones, teeth encode the current members of the SIBLING family of proteins", Connect Tissue Res, 44, pp.33~40 (2003)
- Hunter GK, "Modulation of crystal formation by bone phosphoproteins: role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein", Biochem J, 302, pp.175~179 (1994)
- Malaval L, "Bone sialoprotein plays a functional role in bone formation, osteoclastogenesis", J Exp Med, 205, pp.1145~1153 (2008)
- Barnes GL, "Osteoblastrelated transcription factors Runx2(Cbfa1", AML3), MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells, 2003, pp.63, 2631~2637
- 송인선, "GATA4 negatively regulates osteoblast differentiation by downregulation of Runx2", BMB Reports, 47(8), pp.463~468 (2014), 생화학분자생물학회
- Lifang Hu, "Knockdown of microtubule actin crosslinking factor 1 inhibits cell proliferation in MC3T3-E1 osteoblastic cells", BMB Reports, 48(10), pp.583~588 (2015), 생화학분자생물학회
- Kim K, "Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis", J Biol Chem, 280, pp.35209~35216 (2005)
